Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Caribou BiosciencesCRBU | Open-market sale | 02/25 | 02/27 | 6,228 sh | $1.93 | $12,020.04 | −7.8% | |
Barbara G. McClungChief Legal Officer | Caribou BiosciencesCRBU | Open-market sale | 02/24 | 02/24 | 6,938 sh | $1.96 | $13,598.48 | −1.4% |
Caribou BiosciencesCRBU | Open-market sale | 02/24 | 02/24 | 3,147 sh | $1.96 | $6,168.12 | −3.8% | |
Ruhi Ahmad KhanChief Business Officer | Caribou BiosciencesCRBU | Open-market sale | 02/24 | 02/24 | 6,938 sh | $1.96 | $13,598.48 | −6.2% |
Tina M. AlbertsonChief Medical Officer | Caribou BiosciencesCRBU | Open-market sale10b5-1 plan | 02/24 | 02/24 | 1,066 sh | $1.96 | $2,089.36 | −1.5% |
Rachel E. HaurwitzPresident and CEO | Caribou BiosciencesCRBU | Open-market buy | 25/03/14 | 25/03/17 | 20,000 sh | $1.02 | $20,400 | +0.6% |
Barbara G. McClungChief Legal Officer | Caribou BiosciencesCRBU | Open-market sale | 25/02/21 | 25/02/21 | 3,564 sh | $1.35 | $4,811.4 | −0.8% |
Steven KannerChief Scientific Officer | Caribou BiosciencesCRBU | Open-market sale | 25/02/21 | 25/02/21 | 3,564 sh | $1.35 | $4,811.4 | −0.8% |
Ruhi Ahmad KhanChief Business Officer | Caribou BiosciencesCRBU | Open-market sale | 25/02/21 | 25/02/21 | 3,564 sh | $1.35 | $4,811.4 | −5.1% |
Sriram RyaliCFO | Caribou BiosciencesCRBU | Open-market buy | 25/01/29 | 25/01/30 | 17,360 sh | $1.42 | $24,651.2 | No record |
Syed Ali-aamir RizviChief Medical Officer | Caribou BiosciencesCRBU | Open-market sale | 23/01/19 | 23/01/20 | 5,627 sh | $6.31 | $35,506.37 | −8.7% |